JOYA CHANDRA to Precursor Cell Lymphoblastic Leukemia-Lymphoma
This is a "connection" page, showing publications JOYA CHANDRA has written about Precursor Cell Lymphoblastic Leukemia-Lymphoma.
Connection Strength
0.561
-
Combinatorial effects of histone deacetylase inhibitors (HDACi), vorinostat and entinostat, and adaphostin are characterized by distinct redox alterations. Cancer Chemother Pharmacol. 2018 03; 81(3):483-495.
Score: 0.230
-
Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia. PLoS One. 2013; 8(8):e70608.
Score: 0.169
-
Can anthracycline therapy for pediatric malignancies be less cardiotoxic? Curr Oncol Rep. 2010 Nov; 12(6):411-9.
Score: 0.140
-
Central role of Fas-associated death domain protein in apoptosis induction by the mitogen-activated protein kinase kinase inhibitor CI-1040 (PD184352) in acute lymphocytic leukemia cells in vitro. J Biol Chem. 2003 Nov 21; 278(47):47326-39.
Score: 0.021